Category : Gut Microbiota

Faecal microbiota transplantation (FMT) is a therapy targeting the gut microbiome with the strongest evidence for efficacy in the treatment of recurrent Clostridium difficile infection. Although gut microbiota dysbiosis is involved in the pathogenesis of ulcerative colitis, the role of FMT as a therapy for it is still controversial as the two big randomised controlled trials done previously (here; here)…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Faecal microbiota transplantation (FMT) is a therapy targeting the gut microbiome with the strongest evidence for efficacy in the treatment of recurrent Clostridium difficile infection. Although gut microbiota dysbiosis is involved in the pathogenesis of ulcerative colitis, the role of FMT as a therapy for it is still controversial as the two big randomised controlled trials done previously (here; here)…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Hepatic encephalopathy is a brain dysfunction involving neurological and psychiatric changes associated with liver insufficiency or portal-systemic shunting with a severity that ranges from minor symptoms to coma. There have been reported differences in gut microbiota between those with and without hepatic encephalopathy. A previous Cochrane systematic review including 38 randomised clinical trials on non-absorbable disaccharides (lactulose and lactitol) versus…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Hepatic encephalopathy is a brain dysfunction involving neurological and psychiatric changes associated with liver insufficiency or portal-systemic shunting with a severity that ranges from minor symptoms to coma. There have been reported differences in gut microbiota between those with and without hepatic encephalopathy. A previous Cochrane systematic review including 38 randomised clinical trials on non-absorbable disaccharides (lactulose and lactitol) versus…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Celiac disease (CeD) is a complex immune mediated disorder that is triggered by abnormal immune responses to the dietary protein gluten, which is found in grains like wheat, barley, and rye. Normally, immune tolerance to dietary proteins prevents inflammatory immune responses from developing. However, in those with CeD, the presence of HLA susceptibility genes plus unknown environmental or immune triggers…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.

Celiac disease (CeD) is a complex immune mediated disorder that is triggered by abnormal immune responses to the dietary protein gluten, which is found in grains like wheat, barley, and rye. Normally, immune tolerance to dietary proteins prevents inflammatory immune responses from developing. However, in those with CeD, the presence of HLA susceptibility genes plus unknown environmental or immune triggers…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.

On March 11th and 12th, nearly 400 scientists and healthcare professionals (gastroenterologists, paediatricians, nutritionists, dieticians, and others) from five continents converged in Paris (France) for the 6th edition of the Gut Microbiota for Health World Summit. After the intensive weekend of knowledge sharing about gut microbiota and health from scientific experts from all over the world, the Gut Microbiota for…

GMFH Editing Team
GMFH Editing Team

On March 11th and 12th, nearly 400 scientists and healthcare professionals (gastroenterologists, paediatricians, nutritionists, dieticians, and others) from five continents converged in Paris (France) for the 6th edition of the Gut Microbiota for Health World Summit. After the intensive weekend of knowledge sharing about gut microbiota and health from scientific experts from all over the world, the Gut Microbiota for…

GMFH Editing Team
GMFH Editing Team

Mutualistic interactions between host and commensal microbiota have a pivotal role in colonization resistance (CR), protection against infections by enteric pathogens such as Salmonella spp. Previous research supporting this idea includes a study of the commensal bacterium Enterococcus faecium found in the mammals’ intestines that may improve host intestinal barrier function and limit the pathogenesis of infections caused by Salmonella…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Mutualistic interactions between host and commensal microbiota have a pivotal role in colonization resistance (CR), protection against infections by enteric pathogens such as Salmonella spp. Previous research supporting this idea includes a study of the commensal bacterium Enterococcus faecium found in the mammals’ intestines that may improve host intestinal barrier function and limit the pathogenesis of infections caused by Salmonella…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

The 2017 Gut Microbiota for Health World Summit is quickly approaching! About 400 scientists and healthcare professionals (gastroenterologists, paediatricians, nutritionists and dieticians…) from five continents will converge in Paris (France) on March 11th and 12th for a unique educational experience focused on gut microbiota science. The publishing team of Gut Microbiota for Health is preparing for an intensive weekend of…

GMFH Editing Team
GMFH Editing Team

The 2017 Gut Microbiota for Health World Summit is quickly approaching! About 400 scientists and healthcare professionals (gastroenterologists, paediatricians, nutritionists and dieticians…) from five continents will converge in Paris (France) on March 11th and 12th for a unique educational experience focused on gut microbiota science. The publishing team of Gut Microbiota for Health is preparing for an intensive weekend of…

GMFH Editing Team
GMFH Editing Team

A recent study led by Dr. Jun Sun (Department of Medicine, University of Illinois, Chicago, USA) has found that butyrate, a bacterial metabolic by-product, may normalize the intestinal environment, including gut microbiota composition, and increase life span in a mouse model of amyotrophic lateral sclerosis (ALS). In humans, ALS (also known as Lou Gehrig’s disease) is a neurodegenerative disease in…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

A recent study led by Dr. Jun Sun (Department of Medicine, University of Illinois, Chicago, USA) has found that butyrate, a bacterial metabolic by-product, may normalize the intestinal environment, including gut microbiota composition, and increase life span in a mouse model of amyotrophic lateral sclerosis (ALS). In humans, ALS (also known as Lou Gehrig’s disease) is a neurodegenerative disease in…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous research has shown that the gut microbiota may have a role in the pathogenesis of immune-related diseases involving chronic inflammation, such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis, and others. A recent review, led by Dr. Hai Lu from the Department of Orthopedic Surgery at The Third Affiliated Hospital of Southern Medical University in Guangzhou (China), discusses the existing…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous research has shown that the gut microbiota may have a role in the pathogenesis of immune-related diseases involving chronic inflammation, such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis, and others. A recent review, led by Dr. Hai Lu from the Department of Orthopedic Surgery at The Third Affiliated Hospital of Southern Medical University in Guangzhou (China), discusses the existing…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

On November 24th 2016, the Gairdner Foundation and the Farncombe Institute at McMaster University (Canada) held a joint symposium, “The Intestinal Microbiome: Beyond Associations and into the Clinic”. The meeting was organized by Dr. Stephen Collins, director of the Farncombe Institute, and Dr. Janet Rossant, President and Scientific Director of the Gairdner Foundation, and featured leading experts in the microbiome…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.

On November 24th 2016, the Gairdner Foundation and the Farncombe Institute at McMaster University (Canada) held a joint symposium, “The Intestinal Microbiome: Beyond Associations and into the Clinic”. The meeting was organized by Dr. Stephen Collins, director of the Farncombe Institute, and Dr. Janet Rossant, President and Scientific Director of the Gairdner Foundation, and featured leading experts in the microbiome…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.

Gut Microbiota for Health is delighted to share its “Year at a Glance 2016” document, which wraps-up the important achievements and discoveries in gut microbiota science in 2016! In a field that moves forward so rapidly, it can be difficult to keep up with all the scientific developments; in this “Best of 2016” report we recall the year's key concepts…

GMFH Editing Team
GMFH Editing Team

Gut Microbiota for Health is delighted to share its “Year at a Glance 2016” document, which wraps-up the important achievements and discoveries in gut microbiota science in 2016! In a field that moves forward so rapidly, it can be difficult to keep up with all the scientific developments; in this “Best of 2016” report we recall the year's key concepts…

GMFH Editing Team
GMFH Editing Team